It Takes a Village: Automating Plasmid Purification for iGEM

Today’s blog is guest-written by Wihan Adi, a Master’s student majoring in physics at Justus-Liebig-University in Giessen and team member of iGEM Marburg. Although his background is in nuclear and particle physics, his research interests shifted toward affordable biosensors for point-of-care cancer detection, which is how he ended up doing microbiology for iGEM. Back in […]

Sci Comm Tips From An iGEM Judge

Formal judgment in any context is nerve-racking. Scientists, familiar with being judged, rely on others to evaluate (and hopefully accept) everything from a PhD thesis defense to grant proposals and peer-reviewed journal article submissions. The frustrating part is not knowing exactly what the judges are looking for. Sure there are requirements and guidelines to follow—but […]

Announcing the 2019 Promega iGEM Grant Winners

It’s FINALLY time to announce the winners of the 2019 Promega iGEM Grant! We received over 150 applications this year, so picking the top 10 was very tough. As always, we’re impressed by the amazing work iGEM teams are doing in the lab and in their communities. The 10 winners listed below will receive $2,000 […]

Hey, iGEMers! We’re talking to you!

The 2018 iGEM Giant Jamboree is upon us! This Wednesday, October 24th, thousands of you will flood into Boston, weighed down by posters and presentation materials, but energized by the excitement of a non-stop science-packed conference. Promega will also be attending, with a booth full of helpful giveaways and staff standing by to answer all […]

iGEM: Saving the World with Science

Every year, groups of teenagers gather together and brainstorm ways to save the world—with science. The International Genetically Engineered Machine (iGEM) Foundation is a non-profit organization that is dedicated to educating young scientists and enhancing open community and collaboration in the field of synthetic biology. They hold a competition every year with hundreds of teams […]

Synthetic Biology: Minimal Cell, Maximal Opportunity

According to the National Human Genome Research Institute, synthetic biology is “a field of science that involves redesigning organisms for useful purposes by engineering them to have new abilities”. Synthetic biology has a broad range of applications, from manufacturing pharmaceuticals and other biologically active chemicals and biofuels, to accelerating the adoption of plant-based burgers (1). […]

We’re Committing to 100% Renewable Electricity by 2025

In 2021, we unveiled our most ambitious sustainability goals ever. These goals include a 50% reduction in carbon emissions by 2030, as indexed to revenue over a 2019 baseline. In 2022, we announced that renewable sources provided over 20% of our global electricity usage. This year, Promega is excited to announce that we’re committing to […]

It’s Time to Automate Your Plasmid Purification

In the fifty years since the first reported transformation of recombinant plasmids into bacteria (1), plasmid cloning has become one of the pillars of synthetic biology research and manufacturing biopharmaceuticals. But purifying plasmids is no small feat. It can often take hours of hands-on time to go from culture to eluate with low-throughput and time-sensitive […]

Promega Highlights Innovative Work with Brazil Young Researcher Award

In late May 2022, Promega invited the nine finalists for the Promega Brazil Young Researcher Award to present their work at a Student Research Symposium on the Promega Madison campus. The Brazil Young Researcher Award program was created to acknowledge exceptional work by Brazilian students utilizing Promega products in their research. These student researchers were […]

Promega Sourcing Over 20% of Global Electricity from Renewable Sources

Last summer, we announced our most ambitious sustainability goals ever. This year, as part of our annual reporting, we are proud to share that over 20% of our global electricity is supplied by renewable sources. This represents a ten-fold increase in our renewable energy usage over the past three years.